Intercept Pharmaceuticals
Gary Motz Jr. is a seasoned finance professional with extensive experience in financial planning and analysis, having held senior finance management roles at Intercept Pharmaceuticals, AbbVie, and Allergan. Currently serving as Sr. Finance Manager, FP&A at Intercept Pharmaceuticals since September 2022, Gary previously managed global tech operations finance at AbbVie and Allergan. Earlier roles included Business Planning Analysis Manager at Novartis and Senior Financial Reporting Specialist at Novartis Pharmaceuticals, where responsibilities encompassed budgeting, forecasting, financial reporting, and site-based business partnering across various functions. Gary holds a Bachelor's Degree in Finance from SUNY New Paltz.
This person is not in any teams
Intercept Pharmaceuticals
1 followers
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.